127 related articles for article (PubMed ID: 9808435)
21. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
[TBL] [Abstract][Full Text] [Related]
22. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
Pan CC; Chen PC; Chiang H
Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361
[TBL] [Abstract][Full Text] [Related]
24. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma.
Wang HY; Mills SE
Am J Surg Pathol; 2005 May; 29(5):640-6. PubMed ID: 15832088
[TBL] [Abstract][Full Text] [Related]
25. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
Fragale A; Tartaglia M; Wu J; Gelb BD
Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
[TBL] [Abstract][Full Text] [Related]
26. SHP2-interacting transmembrane adaptor protein (SIT), a novel disulfide-linked dimer regulating human T cell activation.
Marie-Cardine A; Kirchgessner H; Bruyns E; Shevchenko A; Mann M; Autschbach F; Ratnofsky S; Meuer S; Schraven B
J Exp Med; 1999 Apr; 189(8):1181-94. PubMed ID: 10209036
[TBL] [Abstract][Full Text] [Related]
27. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases.
Taki A; Nakatani Y; Misugi K; Yao M; Nagashima Y
Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617
[TBL] [Abstract][Full Text] [Related]
28. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
29. Molecular interactions of SHP1 and SHP2 in IL-3-signalling.
Wheadon H; Paling NR; Welham MJ
Cell Signal; 2002 Mar; 14(3):219-29. PubMed ID: 11812650
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms.
Jacob JM; Williamson SR; Gondim DD; Leese JA; Terry C; Grignon DJ; Boris RS
Urology; 2015 Nov; 86(5):956-61. PubMed ID: 26126697
[TBL] [Abstract][Full Text] [Related]
31. Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors.
Tickoo SK; Amin MB; Linden MD; Lee MW; Zarbo RJ
Am J Surg Pathol; 1997 Aug; 21(8):922-30. PubMed ID: 9255255
[TBL] [Abstract][Full Text] [Related]
32. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
[TBL] [Abstract][Full Text] [Related]
33. [Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance].
Rao Q; Zhou XJ; Shi QL; Yin HL; Ma HH; Zhou HB; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):15-8. PubMed ID: 17374232
[TBL] [Abstract][Full Text] [Related]
34. Alpha-methyl CoA racemase expression in renal cell carcinomas.
Molinié V; Balaton A; Rotman S; Mansouri D; De Pinieux I; Homsi T; Guillou L
Hum Pathol; 2006 Jun; 37(6):698-703. PubMed ID: 16733210
[TBL] [Abstract][Full Text] [Related]
35. Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma: Discrimination From Common Renal Cell Carcinoma Subtypes and Benign RCC Mimics on Multiphasic MDCT.
Young JR; Young JA; Margolis DJA; Sauk S; Sayre J; Pantuck AJ; Raman SS
Acad Radiol; 2017 Oct; 24(10):1226-1232. PubMed ID: 28528853
[TBL] [Abstract][Full Text] [Related]
36. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma.
Choi YD; Kim KS; Ryu S; Park Y; Cho NH; Rha SH; Jang JJ; Ro JY; Juhng SW; Choi C
J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941
[TBL] [Abstract][Full Text] [Related]
37. SHP2 associates directly with tyrosine phosphorylated p90 (SNT) protein in FGF-stimulated cells.
Ong SH; Lim YP; Low BC; Guy GR
Biochem Biophys Res Commun; 1997 Sep; 238(1):261-6. PubMed ID: 9299490
[TBL] [Abstract][Full Text] [Related]
38. Morphogenetic movements at gastrulation require the SH2 tyrosine phosphatase Shp2.
Saxton TM; Pawson T
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3790-5. PubMed ID: 10097116
[TBL] [Abstract][Full Text] [Related]
39. Vinculin: its possible use as a marker of normal collecting ducts and renal neoplasms with collecting duct system phenotype.
Kuroda N; Naruse K; Miyazaki E; Hayashi Y; Yoshikawa C; Ashida S; Moriki T; Yamasaki Y; Numoto S; Yamamoto Y; Yamasaki I; Hiroi M; Shuin T; Enzan H
Mod Pathol; 2000 Oct; 13(10):1109-14. PubMed ID: 11048805
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
